drugset / Trial / NCT05887843

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

NCT05887843

Phase 1 Terminated 38 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

This study will compare the PK parameters of the combination test formulation to monotherapy reference products (mometasone furoate and azelastine hydrochloride) in adolescents and young adult patients with seasonal allergic rhinitis.

Timeline

Start
2023-06-08
Primary completion
2023-09-08
Completion
2023-09-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelastine Small molecule 140 ug Intranasal
Subject Mometasone furoate Other / unclassified 50 ug Intranasal